Novel AI-Enhanced Imagery Rescripting Trial Opens for Generalized Anxiety — Exploring Digital Therapeutic Innovation

References

1. 1.Bandelow, B., Michaelis, S., & Wedekind, D. (2017). Treatment of anxiety disorders. Dialogues in Clinical Neuroscience, 19(2), 93-107. https://doi.org/10.31887/DCNS.2017.19.2/bbandelow
2. 2.Dibbets, P., & Arntz, A. (2016). Imagery rescripting: Is incorporation of the most aversive scenes necessary? Memory, 24(5), 683-695. https://doi.org/10.1080/09658211.2015.1043307
3. 3.Plummer, F., Manea, L., Trepel, D., & McMillan, D. (2016). Screening for anxiety disorders with the GAD-7 and GAD-2: A systematic review and diagnostic metaanalysis. General Hospital Psychiatry, 39, 24-31. https://doi.org/10.1016/j.genhosppsych.2016.01.003
4. 4.Stein, D. J., Scott, K. M., de Jonge, P., & Kessler, R. C. (2017). Epidemiology of anxiety disorders: From surveys to nosology and back. Dialogues in Clinical Neuroscience, 19(2), 83-91. https://doi.org/10.31887/DCNS.2017.19.2/dstein
5. 5.Teicher, M. H., & Samson, J. A. (2016). Annual research review: Enduring neurobiological effects of childhood abuse and neglect. Journal of Child Psychology and Psychiatry, 57(3), 241-266. https://doi.org/10.1111/jcpp.12507
6. 6.University of Social Sciences and Humanities, Warsaw. (2024). Optimization of Late Imagery Rescripting Research Using Generative Artificial Intelligence. ClinicalTrials.gov. NCT07565714. https://clinicaltrials.gov/study/NCT07565714